Antiviral Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antiviral Drugs Market to 2027 - Global Analysis and Forecasts by Mechanism of Action (Protease Inhibitors, Nucleotide Polymerase Inhibitor, Reverse Transcriptase Inhibitors, Others); Application (Hepatitis, HIV, Influenza, Herpes, Others); Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) and Geography

Report Code: TIPRE00004068 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antiviral drugs are used in the treatment of an infectious disease caused by a virus. The viruses are responsible for illnesses such as HIV/AIDS, influenza, herpes simplex type I (cold sores of the mouth) and type II (genital herpes), herpes zoster (shingles), viral hepatitis, encephalitis, infectious mononucleosis and the common cold. Antiviral drugs are different from the antibiotics that are specifically used in the treatment of viral infections. These drugs are prescription medicines that include pills, liquid, an inhaled powder, or an intravenous solution. Antiviral drugs are different from antibiotics, which fight against bacterial infections.

MARKET DYNAMICS
The antiviral drugs market is anticipated to grow due to the key driving factors such as increase in the incidence rate of viral infections, increasing awareness and rising demand for better treatment across the globe. However, rise in R&D activities and development of newer & advanced formulations, such as vaccines and combination therapy are likely to grow the market during the forecast period.

MARKET SCOPE
The "Global Antiviral Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of antiviral drugs market with detailed market segmentation by mechanism of action, application and distribution channel. The global antiviral drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antiviral drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antiviral drugs market is segmented on the basis of mechanism of action, application and distribution channel. On the basis of mechanism of action, the market is segmented as, protease inhibitors, nucleotide polymerase inhibitor, reverse transcriptase inhibitors and others. Based on application, the antiviral drugs market is categorized as hepatitis, HIV, influenza, herpes and others. On the basis of distribution channel, the antiviral drugs market is segmented as, hospitals pharmacies, retail pharmacies and online pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antiviral drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antiviral drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antiviral drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antiviral drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the antiviral drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from antiviral drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antiviral drugs market in the global market. Below mentioned is the list of few companies engaged in the antiviral drugs market.

The report also includes the profiles of key antiviral drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc.
  • Merck & Co., Inc.
  • Gilead Sciences, Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Mylan N.V.
  • Dr. Reddy's Laboratories Ltd
  • Cipla Inc.
  • Aurobindo Pharma
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antiviral Drugs Market - By Mechanism of Action
1.3.2 Antiviral Drugs Market - By Application
1.3.3 Antiviral Drugs Market - By Distribution Channel
1.3.4 Antiviral Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIVIRAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIVIRAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIVIRAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIVIRAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIVIRAL DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - MECHANISM OF ACTION
7.1. OVERVIEW
7.2. MECHANISM OF ACTION MARKET FORECASTS AND ANALYSIS
7.3. PROTEASE INHIBITORS
7.3.1. Overview
7.3.2. Protease Inhibitors Market Forecast and Analysis
7.4. NUCLEOTIDE POLYMERASE INHIBITOR
7.4.1. Overview
7.4.2. Nucleotide Polymerase Inhibitor Market Forecast and Analysis
7.5. REVERSE TRANSCRIPTASE INHIBITORS
7.5.1. Overview
7.5.2. Reverse Transcriptase Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEPATITIS
8.3.1. Overview
8.3.2. Hepatitis Market Forecast and Analysis
8.4. HIV
8.4.1. Overview
8.4.2. HIV Market Forecast and Analysis
8.5. INFLUENZA
8.5.1. Overview
8.5.2. Influenza Market Forecast and Analysis
8.6. HERPES
8.6.1. Overview
8.6.2. Herpes Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. ANTIVIRAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online pharmacies Market Forecast and Analysis
10. ANTIVIRAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antiviral Drugs Market Overview
10.1.2 North America Antiviral Drugs Market Forecasts and Analysis
10.1.3 North America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
10.1.4 North America Antiviral Drugs Market Forecasts and Analysis - By Application
10.1.5 North America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Antiviral Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antiviral Drugs Market
10.1.6.1.1 United States Antiviral Drugs Market by Mechanism of Action
10.1.6.1.2 United States Antiviral Drugs Market by Application
10.1.6.1.3 United States Antiviral Drugs Market by Distribution Channel
10.1.6.2 Canada Antiviral Drugs Market
10.1.6.2.1 Canada Antiviral Drugs Market by Mechanism of Action
10.1.6.2.2 Canada Antiviral Drugs Market by Application
10.1.6.2.3 Canada Antiviral Drugs Market by Distribution Channel
10.1.6.3 Mexico Antiviral Drugs Market
10.1.6.3.1 Mexico Antiviral Drugs Market by Mechanism of Action
10.1.6.3.2 Mexico Antiviral Drugs Market by Application
10.1.6.3.3 Mexico Antiviral Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Antiviral Drugs Market Overview
10.2.2 Europe Antiviral Drugs Market Forecasts and Analysis
10.2.3 Europe Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
10.2.4 Europe Antiviral Drugs Market Forecasts and Analysis - By Application
10.2.5 Europe Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Antiviral Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antiviral Drugs Market
10.2.6.1.1 Germany Antiviral Drugs Market by Mechanism of Action
10.2.6.1.2 Germany Antiviral Drugs Market by Application
10.2.6.1.3 Germany Antiviral Drugs Market by Distribution Channel
10.2.6.2 France Antiviral Drugs Market
10.2.6.2.1 France Antiviral Drugs Market by Mechanism of Action
10.2.6.2.2 France Antiviral Drugs Market by Application
10.2.6.2.3 France Antiviral Drugs Market by Distribution Channel
10.2.6.3 Italy Antiviral Drugs Market
10.2.6.3.1 Italy Antiviral Drugs Market by Mechanism of Action
10.2.6.3.2 Italy Antiviral Drugs Market by Application
10.2.6.3.3 Italy Antiviral Drugs Market by Distribution Channel
10.2.6.4 Spain Antiviral Drugs Market
10.2.6.4.1 Spain Antiviral Drugs Market by Mechanism of Action
10.2.6.4.2 Spain Antiviral Drugs Market by Application
10.2.6.4.3 Spain Antiviral Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Antiviral Drugs Market
10.2.6.5.1 United Kingdom Antiviral Drugs Market by Mechanism of Action
10.2.6.5.2 United Kingdom Antiviral Drugs Market by Application
10.2.6.5.3 United Kingdom Antiviral Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antiviral Drugs Market Overview
10.3.2 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
10.3.4 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Antiviral Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antiviral Drugs Market
10.3.6.1.1 Australia Antiviral Drugs Market by Mechanism of Action
10.3.6.1.2 Australia Antiviral Drugs Market by Application
10.3.6.1.3 Australia Antiviral Drugs Market by Distribution Channel
10.3.6.2 China Antiviral Drugs Market
10.3.6.2.1 China Antiviral Drugs Market by Mechanism of Action
10.3.6.2.2 China Antiviral Drugs Market by Application
10.3.6.2.3 China Antiviral Drugs Market by Distribution Channel
10.3.6.3 India Antiviral Drugs Market
10.3.6.3.1 India Antiviral Drugs Market by Mechanism of Action
10.3.6.3.2 India Antiviral Drugs Market by Application
10.3.6.3.3 India Antiviral Drugs Market by Distribution Channel
10.3.6.4 Japan Antiviral Drugs Market
10.3.6.4.1 Japan Antiviral Drugs Market by Mechanism of Action
10.3.6.4.2 Japan Antiviral Drugs Market by Application
10.3.6.4.3 Japan Antiviral Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antiviral Drugs Market Overview
10.4.2 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
10.4.4 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Antiviral Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antiviral Drugs Market
10.4.6.1.1 South Africa Antiviral Drugs Market by Mechanism of Action
10.4.6.1.2 South Africa Antiviral Drugs Market by Application
10.4.6.1.3 South Africa Antiviral Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Antiviral Drugs Market
10.4.6.2.1 Saudi Arabia Antiviral Drugs Market by Mechanism of Action
10.4.6.2.2 Saudi Arabia Antiviral Drugs Market by Application
10.4.6.2.3 Saudi Arabia Antiviral Drugs Market by Distribution Channel
10.4.6.3 U.A.E Antiviral Drugs Market
10.4.6.3.1 U.A.E Antiviral Drugs Market by Mechanism of Action
10.4.6.3.2 U.A.E Antiviral Drugs Market by Application
10.4.6.3.3 U.A.E Antiviral Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antiviral Drugs Market Overview
10.5.2 South and Central America Antiviral Drugs Market Forecasts and Analysis
10.5.3 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Mechanism of Action
10.5.4 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Application
10.5.5 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Antiviral Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antiviral Drugs Market
10.5.6.1.1 Brazil Antiviral Drugs Market by Mechanism of Action
10.5.6.1.2 Brazil Antiviral Drugs Market by Application
10.5.6.1.3 Brazil Antiviral Drugs Market by Distribution Channel
10.5.6.2 Argentina Antiviral Drugs Market
10.5.6.2.1 Argentina Antiviral Drugs Market by Mechanism of Action
10.5.6.2.2 Argentina Antiviral Drugs Market by Application
10.5.6.2.3 Argentina Antiviral Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIVIRAL DRUGS MARKET, KEY COMPANY PROFILES
12.1. F. HOFFMANN-LA ROCHE LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK AND CO., INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GILEAD SCIENCES, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BRISTOL-MYERS SQUIBB COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. JOHNSON AND JOHNSON SERVICES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MYLAN N.V.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. DR. REDDY’S LABORATORIES LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CIPLA INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AUROBINDO PHARMA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. F. Hoffmann-La Roche Ltd
2. GlaxoSmithKline plc.
3. Merck & Co., Inc.
4. Gilead Sciences, Inc.
5. Bristol-Myers Squibb Company
6. Johnson & Johnson Services, Inc.
7. Mylan N.V.
8. Dr. Reddy's Laboratories Ltd
9. Cipla Inc.
10. Aurobindo Pharma
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book